|
Subsequent Events (Details) (USD $)
In Millions, unless otherwise specified |
0 Months Ended | 12 Months Ended |
|---|---|---|
|
Feb. 01, 2012
|
Dec. 31, 2011
|
|
| Subsequent Events [Abstract] | ||
| Received certain development, clinical and regulatory expenses, maximum | $ 1.0 | |
| Initial milestone eligible to be recognized | 0.1 | |
| Revenue received within thirty days of the execution of the agreement | 0.9 | |
| Future consideration eligible to be received | 2.0 | |
| Aggregate arrangement consideration amount | 3.0 | |
| Future milestone payments subject to the achievement of platform development milestones and regulatory approval of development milestones | 4.0 | |
| Payments to holders of issued and outstanding convertible promissory notes | $ 1.5 |
| X | ||||||||||
|
- Definition
Additional Future Consideration Eligible To Be Received No definition available.
|
| X | ||||||||||
|
- Definition
Aggregate Arrangement Consideration Amount No definition available.
|
| X | ||||||||||
|
- Definition
Future milestones payable by us to the acquired company upon the achievement of development goals. No definition available.
|
| X | ||||||||||
|
- Definition
Payments To Holders Of Issued And Outstanding Convertible Promissory Notes No definition available.
|
| X | ||||||||||
|
- Definition
Received Certain Development Clinical And Regulatory Expenses, Maximum No definition available.
|
| X | ||||||||||
|
- Definition
Revenue Received Within Thirty Days Of The Execution Of The Agreement No definition available.
|
| X | ||||||||||
|
- Definition
Revenue Recognition Milestone Eligible To Be Received No definition available.
|
| X | ||||||||||
|
- Details
|